“I think a lot of innovation comes from smaller companies, this will be an even bigger trend in the future,” says Fibrocell CEO Pernock, whose own company is focused on treatments for skin diseases and conditions.
On the cobblestone streets in front of the New York Stock Exchange, executives and guests of 500.com gathered for an Opening Bell ceremony to celebrate the company’s newly minted $75.2 million IPO. At the same time but on the other side of the globe, employees at its Shenzhen headquarters were partying into the night, being entertained by a live broadcast of the bell ringing, fireworks, light show and a massive cake, while reporters in Beijing attended 500.com’s media conference.
A leading online sports lottery service provider in China, 500.com priced its IPO at $13 per American Depositary Share (1 ADS = 10 class A ordinary shares). The price topped the estimated $11-13 range. The first trade opened under the symbol WBAI at $20, a 53.85% pop over the...
New York City-based Vince Holding Corp., a high-end contemporary clothing line retailer, will visit the New York Stock Exchange (NYSE) on Monday, Nov. 25 to celebrate the company’s Nov. 22 initial public offering on the NYSE. Vince trades on the NYSE under the ticker symbol “VNCE.”
To highlight this important company milestone, Vince executives including CEO Jill Granoff, CFO Lisa Klinger and President Karin Gregersen will ring the NYSE Opening Bell.
Founded in 2002, Vince is a prominent fashion brand known for its modern effortless style and everyday luxury essentials. The company offers...
From The Trading Floor: An accord brokered between Iran and 6 other countries including the U.S. to surrender nuclear ambitions have markets trading in the green this morning
The number of contracts, Americans signed to buy previously owned homes unexpectedly fell in October to -0.6%, the 5th consecutive month amid higher borrowing costs.
Dallas Fed Manufacturing Activity is at 10:30
Western powers signed a deal with Iran to curb its nuclear enrichment activity. In exchange for reducing and diluting stockpiles of highly enriched uranium and beefing up international monitoring of enrichment facilities, the U.S. and E.U. agreed to lift certain sanctions that the White House claimed had cost Iran $80 billion.
The Bank of Japan expects its 2% inflation target "to be reached sometime in late fiscal year 2014 or early fiscal year 2015,
Japanese consumer data continues to disappoint, as...
Ahead of the Bell: Dow futures are trading up 67 points and S&P futures are trading up 6 pointssuggesting major averages would extend a rally that has taken them to repeated all-time highs, though energy shares will be in focus amid a sharp decline in crude oil prices. Global shares were lifted after Iran agreed to limit its nuclear program in exchange for as much as $7 billion in relief from economic sanctions over six months. Iranian Foreign Minister Mohammad Javad Zarif and U.S. Secretary of State John Kerry announced the agreement yesterday after five days of talks in Geneva.
On the economic calendar today, October pending home sales will be released after the market opens and a 1.5% increase is expected, vs. a 5.6% drop in September. The Dallas Fed manufacturing survey for November is also due out after the market opens and economists are forecasting a reading of 3.8, compared to a 3.6 the...
Ludovic Lastennet, CEO and co-founder, opens the European trading day in Paris.
Founded in 2007 and based near Bordeaux, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery. Its flagship product, the JAZZ latest-generation implant, aims to improve the treatment of spinal pathologies requiring vertebral fusion surgery. IMPLANET’s proven orthopedic platform, based on perfectly controlling the traceability of its products, gives the Company the proven ability to enhance this innovation. Protected by four families of international patents, JAZZ has obtained 510(k) regulatory approval from the Food and Drug Administration (FDA) in the United States and the CE mark. IMPLANET employs 33 staff and recorded 2012 sales of €6.6 million.